- Home
- QD vs BBNX Comparison
QD vs BBNX Comparison
Compare QD & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- BBNX
- Stock Information
- Founded
- QD 2014
- BBNX 2015
- Country
- QD China
- BBNX United States
- Employees
- QD N/A
- BBNX N/A
- Industry
- QD Finance: Consumer Services
- BBNX Medical/Dental Instruments
- Sector
- QD Finance
- BBNX Health Care
- Exchange
- QD Nasdaq
- BBNX Nasdaq
- Market Cap
- QD 754.6M
- BBNX 740.7M
- IPO Year
- QD 2017
- BBNX 2025
- Fundamental
- Price
- QD $4.27
- BBNX $25.37
- Analyst Decision
- QD
- BBNX Strong Buy
- Analyst Count
- QD 0
- BBNX 10
- Target Price
- QD N/A
- BBNX $24.40
- AVG Volume (30 Days)
- QD 525.5K
- BBNX 653.2K
- Earning Date
- QD 08-13-2025
- BBNX 11-06-2025
- Dividend Yield
- QD N/A
- BBNX N/A
- EPS Growth
- QD N/A
- BBNX N/A
- EPS
- QD 0.42
- BBNX N/A
- Revenue
- QD $19,058,373.00
- BBNX $69,830,000.00
- Revenue This Year
- QD N/A
- BBNX $42.80
- Revenue Next Year
- QD N/A
- BBNX $34.58
- P/E Ratio
- QD $9.76
- BBNX N/A
- Revenue Growth
- QD N/A
- BBNX 38911.17
- 52 Week Low
- QD $1.77
- BBNX $8.89
- 52 Week High
- QD $5.08
- BBNX $25.63
- Technical
- Relative Strength Index (RSI)
- QD 48.56
- BBNX 83.61
- Support Level
- QD $4.08
- BBNX $18.12
- Resistance Level
- QD $4.32
- BBNX $25.63
- Average True Range (ATR)
- QD 0.18
- BBNX 1.26
- MACD
- QD -0.09
- BBNX 0.68
- Stochastic Oscillator
- QD 24.36
- BBNX 97.01
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.